The Bure Equity- and Creades-backed pure-play MEMS foundry priced at SEK 81 per share, with the offering oversubscribed several times. Cornerstone investors, including Capital Research, Fidelity, AFA, AP2, AP3, AP4, Swedbank Robur, and Carnegie, took roughly three-quarters of the deal.
Silex Microsystems opened sharply higher on its Nasdaq Stockholm debut on Wednesday, with the chipmaker’s shares climbing in early trade after the IPO priced at SEK 81 a share. The offering had been oversubscribed several times in the bookbuild and was placed almost entirely with institutional cornerstones, leaving little float for retail demand on opening day.
The deal raised approximately SEK 1.99bn ($217m) on a 24.6-million-share offering, with the equity valuation at IPO around SEK 8.9bn. The trading symbol is SILEX. Settlement is scheduled for 11 May.
Silex describes itself as the world’s leading pure-play MEMS foundry. The company manufactures micro-electromechanical systems for customers in automotive, industrial, life sciences, and consumer electronics, operating from a single fab in Järfälla, just outside Stockholm, on 200mm wafer production.
The pure-play model means Silex builds chips designed by other companies rather than designing its own product, the equivalent of TSMC’s relationship with fabless semiconductor designers but in the much smaller MEMS niche.
The financials behind the listing are unusually clean for a recent European chip IPO. Net sales for the year ended 31 December 2025 reached SEK 1,385m, with EBIT of SEK 368m, an operating margin around 27 per cent. First-quarter 2026 numbers were stronger still, with SEK 375m of revenue and SEK 128m of EBIT, an operating margin above 34 per cent. Those are the kind of figures that make a pure-play foundry attractive to the institutional cornerstone investors that took most of the deal.
The cornerstone slate is the part of the announcement that sets the stock’s likely trading dynamic. Cornerstones together purchased ordinary shares for approximately SEK 1.501bn, representing about 75 per cent of the offering. The list spans Creades, AFA Insurance, Tredje AP-fonden, Capital Research Global Investors, Swedbank Robur Fonder, Fjärde AP-fonden, Andra AP-fonden, Fidelity International, and Carnegie Fonder.
The combination of three Swedish national pension funds, two of the country’s largest fund managers, two major US institutional investors, and the largest insurance company in Sweden is an unusually deep cornerstone book for a Stockholm chip listing.
Post-IPO ownership stays concentrated. Bure Equity retains roughly 34.2 per cent of the outstanding ordinary shares, and Creades holds about 10.1 per cent. The two firms led the original investor consortium that acquired Silex from its previous Chinese-state-aligned owner in 2023, a transaction that returned the company to Swedish ownership after roughly seven years under Sai MicroElectronics.
That ownership transition is the relevant backstory: Silex spent the latter half of the 2010s as a Swedish-domiciled fab inside a Chinese-controlled corporate structure, until the geopolitical realignment of 2022 and 2023 made that arrangement commercially and politically untenable.
The MEMS market itself has been growing on AI-adjacent demand. Recent contracted volume includes a high-volume manufacturing partnership with Norwegian audio specialist sensiBel for studio-quality MEMS microphones, a category where the underlying processor demand is being driven by the same on-device AI workloads scaling through the broader semiconductor industry.
Silex’s customer base is broader than any single end-market, but the same demand pattern that has supported foundry capacity additions globally is part of why a pure-play MEMS operator is now able to clear a Stockholm IPO at this multiple.
Two questions are unresolved on the public record. The first is the magnitude of Wednesday’s debut-day move; Bloomberg’s framing was that shares soared, but the precise percentage is not yet in the secondary coverage. The second is what Silex does with the IPO proceeds.
The prospectus indicates capacity expansion at the Järfälla facility and balance-sheet flexibility for selective acquisitions in the broader MEMS supply chain. Whether the company can deploy the capital faster than the wider AI-driven demand cycle holds up will be the first thing investors look for in the company’s quarterly disclosures.
For now, the listing has done what it set out to do. Silex has cleared a public-market valuation around SEK 8.9bn enterprise value, attracted a deep cornerstone book, and given Bure Equity and Creades a partial path to monetisation while keeping a controlling combined stake. The next checkpoint is the Q2 print, which will be the first reporting cycle in which Silex operates as a public company.
Stephan is the sports journalist for the Maple Grove Report.
